Tennor Therapeutics (Suzhou) Co., Ltd.

Active trials

• phase2A Phase 1/2 Study to Evaluate the Safety, PK and Efficacy of TNP-2092 Administered Via IA Injection in PJI Participantsrecruitingn=33
• phase3Efficacy and Safety of Rifasutenizol (TNP 2198), Rabeprazole and Amoxicillin in Participants With H. Pylori Infectioncompletedn=700
• phase2PK Profile and Preliminary Efficacy of TNP-2092 Capsules in Liver Cirrhosis Patients With Hyperammonemiacompletedn=36
• phase1A Phase 1 Study to Evaluate PK Profile and Food Effects on PK Parameters of TNP-2092 Capsulescompletedn=58
• phase1A Phase 1 Study to Evaluate PK Profile of Multiple Oral Administrations of TNP-2092 Capsules in Healthy Subjectscompletedn=40
• phase1Drug-Drug Interactions Between TNP-2198 and Midazolam, Clarithromycincompletedn=32
• phase1Phase 1, Single-Dose and Multiple-Dose Continuous Intravenous Infusions of TNP-2092 for Injection in Healthy Chinese Participantscompletedn=32
• phase1The Safety and Tolerability, Pharmacokinetics of TNP-2092 Capsules in Combination With Rabeprazole Sodium Enteric-coated Tabletscompletedn=20